{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:56:58Z","timestamp":1792609018425,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.hrtlng.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T05:25:55Z","timestamp":1654579555000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils"],"prefix":"10.1016","volume":"56","author":[{"given":"Wang","family":"Ruiying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zhaoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jianying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.hrtlng.2022.05.012_bib0001","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5588\/ijtld.19.0397","article-title":"The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries","volume":"23","author":"Halpin","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0002","unstructured":"Global Initiative For Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2021 report. http:\/\/www.goldcopd.org"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0003","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/COPD.S128604","article-title":"The recent advances of phenotypes in acute exacerbations of COPD","volume":"12","author":"Zhou","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0004","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.rmed.2017.07.064","article-title":"Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD","volume":"131","author":"Prins","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0005","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/COPD.S129787","article-title":"Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD","volume":"12","author":"Zysman","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9","key":"10.1016\/j.hrtlng.2022.05.012_bib0006","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.05.012_bib0007","first-page":"426","article-title":"Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD","volume":"42","author":"Xue","year":"2019","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.05.012_bib0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1060028018799696","article-title":"Systemic corticosteroid and anti-biotic use in hospitalized patients with chronic obstruc- tive pulmonary disease exacerbation","volume":"53","author":"Petite","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0009","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S187375","article-title":"Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths","volume":"14","author":"Li","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1059079","article-title":"Clinical differences between eosinophilic and noneosinophilic acute exacerbation of chronic obstructive pulmonary disease: a multicenter cross-sectional study","volume":"2020","author":"Dai","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.05.012_bib0011","first-page":"3451","article-title":"The expression and the clinical significance of eosinophils, PCT and CRP in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with pulmonary infection","volume":"13","author":"Zhou","year":"2021","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjms.2021.02.013","article-title":"Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"362","author":"Yu","year":"2021","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.21037\/jtd-20-2178","article-title":"The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD)","volume":"13","author":"Lv","year":"2021","journal-title":"J Thorac Dis"},{"issue":"13","key":"10.1016\/j.hrtlng.2022.05.012_bib0014","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.12998\/wjcc.v8.i13.2727","article-title":"Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease","volume":"8","author":"Wu","year":"2020","journal-title":"World J Clin Cases"},{"issue":"12","key":"10.1016\/j.hrtlng.2022.05.012_bib0015","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"SPIROMICS investigators. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/COPD.S194367","article-title":"Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts","volume":"14","author":"M\u00fcllerov\u00e1","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0017","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1183\/09031936.00062614","article-title":"Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis","volume":"44","author":"Bafadhel","year":"2014","journal-title":"Eur Respir J"},{"issue":"19-20","key":"10.1016\/j.hrtlng.2022.05.012_bib0018","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00508-014-0690-6","article-title":"Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil\/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD","volume":"127","author":"Tanr\u0131verdi","year":"2015","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.hrtlng.2022.05.012_bib0019","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/15412555.2021.1976739","article-title":"Evaluation of blood markers at admission for predicting community acquired pneumonia in chronic obstructive pulmonary disease","volume":"18","author":"Gao","year":"2021","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chest.2019.02.406","article-title":"Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD","volume":"156","author":"MacDonald","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0021","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/COPD.S197361","article-title":"The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Choi","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.05.012_bib0022","first-page":"791","article-title":"The human eosinophil: roles in hostdefense and tissue injury","volume":"100","author":"Weller","year":"1980","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.05.012_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12016-015-8525-4","article-title":"The eosinophil in infection","volume":"50","author":"Ravin","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0024","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.3389\/fimmu.2018.02763","article-title":"Eosinophil extracellular traps and inflammatory pathologies-untangling the web!","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.hrtlng.2022.05.012_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11882-019-0867-1","article-title":"Eosinophils: nemeses of pulmonary pathogens?","volume":"19","author":"LeMessurier","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","article-title":"Pattern-recognition receptors in human eosinophils","volume":"136","author":"Kvarnhammar","year":"2012","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0027","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-12-10","article-title":"Analysing the eosinophil cationic protein\u2013a clue to the function of the eosinophil granulocyte","volume":"12","author":"Bystrom","year":"2011","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.05.012_bib0028","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/IAI.69.6.3591-3596.2001","article-title":"Bactericidal activity of human eosinophilic granulocytes against Escherichia coli","volume":"69","author":"Persson","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.hrtlng.2022.05.012_bib0029","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm.1855","article-title":"Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense","volume":"14","author":"Yousefi","year":"2008","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-017-0570-5","article-title":"Blood and sputum eosinophils in COPD; relationship with bacterial load","volume":"18","author":"Kolsum","year":"2017","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.05.012_bib0031","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI108166","article-title":"Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation","volume":"56","author":"Bass","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0032","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Walters","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.hrtlng.2022.05.012_bib0033","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/jim-2019-001105","article-title":"Optimal glucocorticoid dose and the effects on mortality, length of stay, and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)","volume":"67","author":"Kichloo","year":"2019","journal-title":"J Investig Med"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0034","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.hrtlng.2022.05.012_bib0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood Eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.hrtlng.2022.05.012_bib0036","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0037","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/15412555.2015.1057276","article-title":"Predicting in-hospital treatment failure (\u2264 7 days) in patients with COPD exacerbation using antibiotics and systemic steroids","volume":"13","author":"Crisafulli","year":"2016","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.05.012_bib0038","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.200906-0837OC","article-title":"Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"181","author":"Daniels","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.05.012_bib0039","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1183\/09031936.00150211","article-title":"Sputum purulence- guided antibiotic use in hospitalised patients with exacerbations of COPD","volume":"40","author":"Soler","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.05.012_bib0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1183\/09031936.00002913","article-title":"Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation","volume":"43","author":"Abroug","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0041","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pupt.2016.03.004","article-title":"Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study","volume":"37","author":"Serafino-Agrusa","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0042","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pupt.2014.09.004","article-title":"Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD","volume":"31","author":"Sun","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0043","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/B:APPT.0000012126.06126.c4","article-title":"Differential control of eosinophil survival by glucocorticoids","volume":"9","author":"Bloom","year":"2004","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.hrtlng.2022.05.012_bib0044","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0045","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/COPD.S226783","article-title":"Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Wu","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.05.012_bib0046","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000510516","article-title":"Blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"100","author":"You","year":"2021","journal-title":"Respiration"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0047","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2147\/COPD.S347948","article-title":"Eosinopenia predicting long-term mortality in hospitalized acute exacerbation of COPD patients with community-acquired pneumonia-a retrospective analysis","volume":"16","author":"Mao","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.hrtlng.2022.05.012_bib0048","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2147\/COPD.S245056","article-title":"Blood Eosinophilia and its stability in hospitalized COPD exacerbations are associated with lower risk of all-cause mortality","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.05.012_bib0049","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12931-020-1310-9","article-title":"Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease","volume":"21","author":"Salvi","year":"2020","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.hrtlng.2022.05.012_bib0050","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956322001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956322001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:39:05Z","timestamp":1758955145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956322001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":50,"alternative-id":["S0147956322001212"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.05.012","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}